JP2005533604A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005533604A5 JP2005533604A5 JP2004524538A JP2004524538A JP2005533604A5 JP 2005533604 A5 JP2005533604 A5 JP 2005533604A5 JP 2004524538 A JP2004524538 A JP 2004524538A JP 2004524538 A JP2004524538 A JP 2004524538A JP 2005533604 A5 JP2005533604 A5 JP 2005533604A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- agents
- poly
- tissue
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 14
- 229940124597 therapeutic agent Drugs 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 239000003112 inhibitor Substances 0.000 claims 5
- -1 parilast Polymers 0.000 claims 4
- 229920006217 cellulose acetate butyrate Polymers 0.000 claims 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims 2
- 108091008605 VEGF receptors Proteins 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 229960003444 immunosuppressant agent Drugs 0.000 claims 2
- 230000001861 immunosuppressant effect Effects 0.000 claims 2
- 239000003018 immunosuppressive agent Substances 0.000 claims 2
- 239000002207 metabolite Substances 0.000 claims 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims 2
- 239000011148 porous material Substances 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims 1
- 229940127291 Calcium channel antagonist Drugs 0.000 claims 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 claims 1
- 108091008794 FGF receptors Proteins 0.000 claims 1
- 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 claims 1
- 101150097381 Mtor gene Proteins 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 102000003945 NF-kappa B Human genes 0.000 claims 1
- 108010057466 NF-kappa B Proteins 0.000 claims 1
- 108091008604 NGF receptors Proteins 0.000 claims 1
- 102000007339 Nerve Growth Factor Receptors Human genes 0.000 claims 1
- 239000004677 Nylon Substances 0.000 claims 1
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 229920002873 Polyethylenimine Polymers 0.000 claims 1
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 claims 1
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 claims 1
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 claims 1
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 claims 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000003510 anti-fibrotic effect Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 230000001028 anti-proliverative effect Effects 0.000 claims 1
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 239000003146 anticoagulant agent Substances 0.000 claims 1
- 229940034982 antineoplastic agent Drugs 0.000 claims 1
- 229940127218 antiplatelet drug Drugs 0.000 claims 1
- 229960004676 antithrombotic agent Drugs 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- MYXPLUNESFFVPY-UHFFFAOYSA-N butanoic acid;methyl 2-methylprop-2-enoate Chemical compound CCCC(O)=O.COC(=O)C(C)=C MYXPLUNESFFVPY-UHFFFAOYSA-N 0.000 claims 1
- 239000000480 calcium channel blocker Substances 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 claims 1
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 claims 1
- 239000001177 diphosphate Substances 0.000 claims 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims 1
- 235000011180 diphosphates Nutrition 0.000 claims 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 1
- 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 1
- 229920001778 nylon Polymers 0.000 claims 1
- KASDHRXLYQOAKZ-ZPSXYTITSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-ZPSXYTITSA-N 0.000 claims 1
- 229960005330 pimecrolimus Drugs 0.000 claims 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 claims 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims 1
- 229920000052 poly(p-xylylene) Polymers 0.000 claims 1
- 229920002401 polyacrylamide Polymers 0.000 claims 1
- 229920000515 polycarbonate Polymers 0.000 claims 1
- 239000004417 polycarbonate Substances 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000004926 polymethyl methacrylate Substances 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
- 239000004800 polyvinyl chloride Substances 0.000 claims 1
- 230000000861 pro-apoptotic effect Effects 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 claims 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 claims 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 claims 1
- 229940124549 vasodilator Drugs 0.000 claims 1
- 239000003071 vasodilator agent Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/206,807 US20030050692A1 (en) | 2000-12-22 | 2002-07-25 | Delivery of therapeutic capable agents |
| US40462402P | 2002-08-19 | 2002-08-19 | |
| US45414603P | 2003-03-11 | 2003-03-11 | |
| US47253603P | 2003-05-21 | 2003-05-21 | |
| PCT/US2003/020492 WO2004010900A1 (en) | 2002-07-25 | 2003-06-27 | Devices delivering therapeutic agents and methods regarding the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005533604A JP2005533604A (ja) | 2005-11-10 |
| JP2005533604A5 true JP2005533604A5 (enExample) | 2006-07-20 |
Family
ID=31192340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004524538A Pending JP2005533604A (ja) | 2002-07-25 | 2003-06-27 | 治療薬を送達する装置とこれに関する方法 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1539041A1 (enExample) |
| JP (1) | JP2005533604A (enExample) |
| AU (1) | AU2003261100A1 (enExample) |
| WO (1) | WO2004010900A1 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7713297B2 (en) | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
| WO2003064383A2 (en) * | 2002-02-01 | 2003-08-07 | Ariad Gene Therapeutics, Inc. | Phosphorus-containing compounds & uses thereof |
| US20060271168A1 (en) * | 2002-10-30 | 2006-11-30 | Klaus Kleine | Degradable medical device |
| US20090093875A1 (en) | 2007-05-01 | 2009-04-09 | Abbott Laboratories | Drug eluting stents with prolonged local elution profiles with high local concentrations and low systemic concentrations |
| ES2437590T3 (es) | 2004-03-02 | 2014-01-13 | The Johns-Hopkins University | Mutaciones del gen de PIK3CA en cánceres humanos |
| WO2005097222A1 (en) * | 2004-03-26 | 2005-10-20 | Surmodics, Inc. | Process and systems for biocompatible surfaces |
| CA2559756A1 (en) * | 2004-04-02 | 2005-10-13 | Novartis Ag | Vegf receptor tyrosine kinase inhibitor coated stent |
| GB0410749D0 (en) * | 2004-05-14 | 2004-06-16 | Dow Corning Ireland Ltd | Coating apparatus |
| US7794490B2 (en) * | 2004-06-22 | 2010-09-14 | Boston Scientific Scimed, Inc. | Implantable medical devices with antimicrobial and biodegradable matrices |
| JP5312018B2 (ja) * | 2005-04-05 | 2013-10-09 | エリクシアー メディカル コーポレイション | 分解性の移植可能な医療装置 |
| US7449442B2 (en) * | 2005-07-12 | 2008-11-11 | Children's Medical Center Corporation | EGFR inhibitors promote axon regeneration |
| US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
| US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
| US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
| JP2009542359A (ja) | 2006-06-29 | 2009-12-03 | ボストン サイエンティフィック リミテッド | 選択的被覆部を備えた医療装置 |
| WO2008033711A2 (en) | 2006-09-14 | 2008-03-20 | Boston Scientific Limited | Medical devices with drug-eluting coating |
| US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
| JP2008119199A (ja) * | 2006-11-10 | 2008-05-29 | Kagoshima Univ | カルシニューリン産生亢進を抑制する薬剤コーティングステント |
| US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
| US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
| US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
| US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
| US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
| US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
| US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
| US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
| US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
| US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
| JP2010535541A (ja) | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | 広い表面積を有する医療器具用のコーティング |
| US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
| US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
| US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
| US20110053852A1 (en) * | 2007-12-21 | 2011-03-03 | Paul Klotman | Use of podocan protein in treating cardiovascular diseases |
| JP5581311B2 (ja) | 2008-04-22 | 2014-08-27 | ボストン サイエンティフィック サイムド，インコーポレイテッド | 無機材料のコーティングを有する医療デバイス及びその製造方法 |
| WO2009132176A2 (en) | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
| WO2009155328A2 (en) | 2008-06-18 | 2009-12-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
| US20100086579A1 (en) * | 2008-10-03 | 2010-04-08 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
| US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
| US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
| US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
| EP3213721B1 (en) * | 2014-10-28 | 2021-06-02 | Jimro Co., Ltd. | Drug-eluting stent |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5545208A (en) * | 1990-02-28 | 1996-08-13 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
| DE69110787T2 (de) * | 1990-02-28 | 1996-04-04 | Medtronic, Inc., Minneapolis, Minn. | Intraluminale prothese mit wirkstoffeluierung. |
| CA2094858C (en) * | 1992-04-28 | 2004-06-15 | Robert D. Mitchell | Method of treating hyperproliferative vascular disease |
| US5283257A (en) * | 1992-07-10 | 1994-02-01 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating hyperproliferative vascular disease |
| US6120536A (en) * | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
| US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
| JP3476604B2 (ja) * | 1995-08-22 | 2003-12-10 | 鐘淵化学工業株式会社 | 薬剤を付着・コーティングしたステントの製造方法 |
| GB0012383D0 (en) * | 2000-05-22 | 2000-07-12 | Novartis Ag | Organic compounds |
| WO2001093871A1 (fr) * | 2000-06-07 | 2001-12-13 | Cardiovascular Institute, Ltd. | Medicaments pour la prevention de la reangiostenose |
| US20050176678A1 (en) * | 2002-05-09 | 2005-08-11 | Roland Horres | Compounds and method for coating surfaces in a haemocompatibe manner |
-
2003
- 2003-06-27 WO PCT/US2003/020492 patent/WO2004010900A1/en not_active Ceased
- 2003-06-27 JP JP2004524538A patent/JP2005533604A/ja active Pending
- 2003-06-27 AU AU2003261100A patent/AU2003261100A1/en not_active Abandoned
- 2003-06-27 EP EP03771553A patent/EP1539041A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005533604A5 (enExample) | ||
| JP2004523275A5 (enExample) | ||
| US6872225B1 (en) | Local drug delivery | |
| JP3954616B2 (ja) | 生物活性物質放出コーティングを提供するための方法およびシステム | |
| KR100314123B1 (ko) | 경피투여시스템에적용가능한공중합체필름및그제조방법 | |
| CN101564571B (zh) | 含有雷帕霉素类似物的医疗装置 | |
| US7833548B2 (en) | Bioactive agent release coating and controlled humidity method | |
| US20020120326A1 (en) | Ethylene-carboxyl copolymers as drug delivery matrices | |
| WO2003024455A3 (en) | Stent coated with a sustained-release drug delivery and method for use thereof | |
| US20050106203A1 (en) | Polyacrylates coating for implantable medical devices | |
| KR20040005936A (ko) | 공동약물을 함유하는 서방 약물 전달 시스템 | |
| US20030229392A1 (en) | Drug eluted vascular graft | |
| CN102427834A (zh) | 用于递送生物活性剂的装置和方法 | |
| JP2008512141A (ja) | 薬物放出に対する自己形成性の速度制御バリアを有する医療用デバイス | |
| JP2004535431A5 (enExample) | ||
| WO2005013936A3 (en) | Manufacture of long term drug delivery devices with polyurethane based polymers | |
| JP2005533604A (ja) | 治療薬を送達する装置とこれに関する方法 | |
| JP2005534408A (ja) | 熱可塑性フルオロポリマーをコーティングした医療装置 | |
| WO2006014969A3 (en) | Medical device having a coating layer with structural elements therein and method of making the same | |
| EP1684820A2 (en) | Active agent delivery systems including a miscible polymer blend, medical devices, and methods | |
| CA2451187A1 (en) | Zero-order prolonged release coaxial implants | |
| EA200600470A1 (ru) | Биосовместимое и биологически стабильное покрытие медицинских поверхностей | |
| WO1998029095A3 (en) | Sustained release cisapride mini-tablet formulation | |
| KR20170016884A (ko) | 약물 전달 시스템 및 관련 사용 방법 | |
| WO2006002112A1 (en) | Devices, articles, coatings, and methods for controlled active agent release |